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Introduction
Scoring systems used in critically ill patients can be 
broadly divided into those that are speciﬁ  c for an organ 
or disease (for example, the Glasgow Coma Scale (GCS)) 
and those that are generic for all ICU patients. In this 
article, we focus on the generic scores, which can broadly 
be divided into scores that assess disease severity on 
admission and use it to predict outcome (for example, 
Acute Physiology and Chronic Health Evaluation 
(APACHE), Simpliﬁ  ed Acute Physiology Score (SAPS), 
Mortality Probability Model (MPM)), scores that assess 
the presence and severity of organ dysfunction (for 
example, Multiple Organ Dysfunction Score (MODS), 
Sequential Organ Failure Assessment (SOFA)), and 
scores that assess nursing workload use (for example, 
Th  era  peutic Intervention Scoring System (TISS), Nine 
Equiva  lents of Nursing Manpower Use Score (NEMS)). 
Th  e objective of this review is to give the intensivist 
without any particular knowledge or expertise in this 
area an overview of the current status of these 
instruments and their possible applications. For a more 
detailed explanation of the development, application and 
limitations of these models, the reader is referred to a 
recent review [1].
Outcome prediction scores
Th  e original outcome prediction scores were developed 
more than 25 years ago to provide an indication of the 
risk of death of groups of ICU patients; they were not 
designed for individual prognostication. Patient demo-
graphics, disease prevalence, and intensive care practice 
have changed considerably since [2], and statistical and 
computational techniques have also progressed. As a 
result, all three of the major scores in this category have 
been recently updated to ensure their continued accuracy 
in today’s ICU (Table 1).
Acute Physiology and Chronic Health Evaluation
Th  e original APACHE score was developed in 1981 to 
classify groups of patients according to severity of illness 
and was divided into two sections: a physiology score to 
assess the degree of acute illness; and a preadmission 
evaluation to determine the chronic health status of the 
patient [3]. In 1985, the original model was revised and 
simpliﬁ  ed to create APACHE II [4], now the world’s most 
widely used severity of illness score. In APACHE II, there 
are just 12 physiological variables, compared to 34 in the 
original score. Th  e  eﬀ  ects of age and chronic health status 
are incorporated directly into the model, weighted 
according to their relative impact, to give a single score 
with a maximum of 71. Th   e worst value recorded during 
the ﬁ  rst 24 hours of a patient’s admission to the ICU is 
used for each physiological variable. Th  e principal 
diagnosis leading to ICU admission is added as a category 
weight so that the predicted mortality is computed based 
on the patient’s APACHE II score and their principal 
diagnosis at admission. Th   e reason for ICU admission is, 
therefore, an important variable in predicting mortality, 
even when previous health status and the degree of acute 
physiological dysfunction are similar.
APACHE III was developed in 1991 [5] and was 
validated and further updated in 1998 [6]. Equations for 
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© 2010 BioMed Central Ltdpredicting risk-adjusted ICU length of stay were also 
developed using the APACHE III model [7]. Most 
recently, APACHE IV was developed using a database of 
over 100,000 patients admitted to 104 ICUs in 45 
hospitals in the USA in 2002/2003, and remodeling 
APACHE III with the same physiological variables and 
weights but diﬀ   erent predictor variables and reﬁ  ned 
statistical methods [8]. APACHE IV again provides ICU 
length of stay prediction equations, which can provide 
benchmarks for the assessment and comparison of ICU 
eﬃ   ciency and resource use [9].
Simplifi  ed Acute Physiology Score
SAPS, developed and validated in France in 1984, used 13 
weighted physiological variables and age to predict risk of 
death in ICU patients [10]. Like the APACHE scores, 
SAPS was calculated from the worst values obtained 
during the ﬁ  rst 24 hours of ICU admission. In 1993, Le 
Gall and colleagues [11] used logistic regression analysis 
to develop SAPS II, which includes 17 variables: 12 
physiological variables, age, type of admission, and 3 
variables related to underlying disease. Th   e SAPS II score 
was validated using data from consecutive admissions to 
137 ICUs in 12 countries [11].
In 2005, a completely new SAPS model, the SAPS 3, 
was created. Complex statistical techniques were used to 
select and weight variables using a database of 16,784 
patients from 303 ICUs in 35 countries [12]. Th  e  SAPS  3 
score includes 20 variables divided into three subscores 
related to patient characteristics prior to admission, the 
circumstance of the admission, and the degree of 
physiological derangement within 1 hour (in contrast to 
the 24-hour time window in the SAPS II model) before or 
after ICU admission. Th   e total score can range from 0 to 
217. Unlike the other scores, SAPS 3 includes customized 
equations for prediction of hospital mortality in seven 
geographical regions: Australasia; Central, South America; 
Central, Western Europe; Eastern Europe; North Europe; 
Southern Europe, Mediterranean; and North America. It 
should be noted that the sample size for development of 
some of these equations was relatively small, which may 
compromise their prognostic accuracy. Th   e SAPS 3 score 
has been shown to exhibit good discrimination, 
calibration, and goodness of ﬁ  t [12]. SAPS 3 has also been 
used to examine variability in resource use between ICUs 
using the standardized resource use parameter based on 
the length of stay in the ICU adjusted for severity of acute 
illness [13].
Mortality Probability Model
Th  e  ﬁ  rst MPM, developed from data from patients in one 
ICU, consisted of an admission model using seven 
admission variables, and a 24-hour model using seven 
24-hour variables [14]. A revised MPM, MPM II, was 
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Table 1. Comparison of general outcome prediction models
   APACHE  SAPS  APACHE  II MPMa  APACHE III  SAPS II  MPM IIb  SAPS 3  APACHE IV  MPM III
Characteristics   [3]   [10]  [4]  [14]  [5]  [11]  [15]  [12]  [8]  [17]
Year    1981 1984 1985  1985 1991 1993 1993 2005 2006 2007
Countries 1 1 1  1 1  12  12  35  1 1
ICUs    2  8  13  1  40  137 140  303 104 135
Patients 705  679  5,815  2,783  17,440  12,997  19,124  16,784  110,558  124,855
Selection of   Panel  Panel  Panel  Multiple  Multiple  Multiple Multiple  Multiple Multiple Multiple
variables and   of  of  of  logistic  logistic  logistic  logistic  logistic  logistic  logistic
their  weights  experts  experts  experts  regression regression regression regression  regression regression regression
Variables           
  Age  No Yes Yes  Yes Yes Yes Yes Yes Yes Yes
  Origin No No No No Yes No No Yes Yes No
  Surgical  status  No No Yes  Yes Yes Yes Yes Yes Yes Yes
  Chronic    Yes No Yes  Yes Yes Yes Yes Yes Yes Yes
 health  status
  Physiology  Yes Yes Yes Yes Yes Yes Yes  Yes Yes Yes
  Acute  diagnosis  No No Yes  No Yes No Yes Yes Yes Yes
Number  of  variables  34 14 17  11 26 17  15c 20  142  16d
Score  Yes Yes Yes No Yes Yes No Yes Yes No
Mortality  prediction  No No Yes  Yes Yes Yes Yes Yes Yes Yes
aThese models are based on previous     versions, developed by the same authors. bThe numbers presented are those for the admission component of the model 
(MPM0 II). cMPM24 II uses only 13 variables. dPlus 7 interaction terms. APACHE, Acute Physiology and Chronic Health Evaluation; SAPS, Simplifi  ed Acute Physiology 
Score; MPM, Mortality Probability Model. Adapted from [64] with permission.
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a large database of 12,610 ICU patients from 12 countries 
[15]. MPM II also consists of two scores: MPM0, the 
admission model, which contains 15 variables; and MPM24 
the 24-hour model, which contains 5 of the admission 
variables and 8 additional variables and is designed for 
patients who stay in the ICU for more than 24 hours. 
Unlike the APACHE and SAPS systems where variables 
are weighted, in MPM II each variable (except age, which 
is entered as the actual age in years), is designated as 
present or absent and given a score of 1 or 0 accordingly. 
A logistic regression equation is then used to provide a 
probability of hospital mortality. Th   e authors also 
developed a Weighted Hospital Days scale (WHD-94) by 
subjectively assigning weights to days in the ICU and to 
hospital days after ICU discharge from the ﬁ  rst ICU stay, 
and an equation to predict an ICU’s mean WHD-94, thus 
providing an index of resource utilization [16].
MPM0 has recently been updated using a database of 
124,885 patients from 135 ICUs in 98 hospitals (all in 
North America except for one in Brazil) collected in 2001 
to 2004 [17]. MPM0-III uses 16 variables, including 3 
physiological parameters, obtained within 1 hour of ICU 
admission to estimate mortality probability at hospital 
discharge; the MPM0 characterization is, therefore, based 
on patient condition largely before ICU care begins. Th  e 
WHD-94 predictive equation has also been updated [18].
Discussion
Several studies have compared the diﬀ  erent  outcome 
prediction scoring systems. For example, in a study of 
10,393 patients from Scottish ICUs, Livingston and 
colleagues [19] compared the APACHE II and III, an 
APACHE II using United Kingdom-derived coeﬃ   cients 
(UK APACHE II), SAPS II, and MPM0 and MPM24. Th  ese 
authors reported that all models showed good discri  mi-
nation, although observed mortality was signiﬁ  cantly 
diﬀ  erent from that predicted by all models. SAPS II had 
the best performance overall, but APACHE II had better 
calibration. In a retrospective study of 11,300 patients 
from 35 hospitals in California, Kuzniewicz and 
colleagues [20] recently used logistic regression to 
re-estimate the coeﬃ   cients for the APACHE IV, MPM0-
III and SAPS II scores and applied the new equations to 
assess risk-adjusted mortality rates. Th   ese authors noted 
that discrimination and calibration were adequate for all 
models, with discrimination of APACHE IV slightly 
better than that of the other two scores (area under the 
receiver operating characteristic curve 0.892 for 
APACHE IV, 0.873 for SAPS II, and 0.809 for MPM0 III, 
P < 0.001).
In addition to using a more geographically hetero-
geneous database for development, the SAPS 3 model 
attempted to address any geographic variation by 
provid  ing separate customized equations of diﬀ  erent 
geographical regions. Nevertheless, local customization 
may still help improve the calibration of these scores in 
individual countries or regions as demonstrated for the 
APACHE III in Cleveland, Ohio [21], or more recently for 
the SAPS 3 score in Austria [22]. In a retrospective 
analysis of prospectively collected data from a surgical 
ICU, Sakr and colleagues [23] reported that the discri  mi-
native ability of SAPS 3 was similar to that of APACHE II 
and SAPS II (area under the receiver operating charac-
teristic curve 0.80 for APACHE II, 0.83 for SAPS II, and 
0.84 for SAPS 3). All three scores had poor calibration, 
which improved after customization to the local popu-
lation. In the UK, investigators have developed a new 
scoring system speciﬁ  cally for use in UK ICU patients 
[24]. Th  is score uses elements of the APACHE, SAPS, 
and MPM systems and was developed using the large 
Intensive Care National Audit and Research Centre 
(ICNARC) database and calibrated for adult critically ill 
patients admitted to ICUs in the UK. It performed better 
than SAPS II, APACHE II and III, and MPM II [24], but 
has not been compared to the latest versions of these 
scores.
When using these instruments, in addition to the issues 
related to local customization and regular updates 
discussed above, a few important limitations should be 
kept in mind. First, all general outcome prediction 
models can only at their best predict the behavior of a 
group of patients that exactly matches the patients in the 
development population. For example, the APACHE and 
MPM scores were largely based on North American 
popu  lations and the SAPS score on European patients, 
while SAPS 3 developers used a database that included a 
geographically more heterogeneous group of patients 
[12]. In addition, in most of the scores, speciﬁ  c 
populations were excluded from the original databases 
(for example, patients with burns, patients aged less than 
16 or 18 years, patients with a very short length of ICU 
stay, and so on).
Second, the accuracy of any scoring system is highly 
dependent on the quality of the input. To be used 
correctly, the deﬁ  nitions, time of data collection, rules for 
missing data, and so on must exactly match those applied 
when building the model. Th   e reported reliability of the 
systems (intra- and inter-observer) must also be taken 
into account.
Th   ird, there is an inherent bias in many of the derived 
equations used to predict mortality in that they are 
created from a limited population of patients from ICUs 
that are speciﬁ   cally interested in measuring (and 
improving) ICU performance.
Fourth, the outcome used in all these instruments is 
the vital status at hospital discharge; consequently, the 
use of other outcome measures (such as the vital status at 
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predictive equations. Nevertheless, some models have 
additional equations to assess use of resources, usually 
measured as risk-adjusted, weighted, ICU- or hospital 
days [9,13,18].
Fifth, the statistical methodology used to assess 
calibration of a predictive model, most commonly the 
Hosmer-Lemeshow statistic, may be inﬂ  uenced  by 
various factors, including the number of covariates being 
assessed, the manner in which observations with equal 
probabilities of outcome are sorted, and the sample size 
(both small and large) [25]. Interpretation of the accuracy 
of predictive models should, therefore, include some 
knowledge of the statistical tests used. Diﬀ  erent statistical 
techniques may be required for the larger models 
increasingly used to develop predictive models, such as 
the use of calibration graphs and, more recently, the Cox 
test of calibration and related statistics [26].
Sixth, despite the fact that predictive models have been 
developed in large populations, in almost all cases when 
they are applied to new populations calibration deterior-
ates, although discrimination hardly changes. Two recent 
examples of this eﬀ  ect were given in validation studies of 
SAPS 3 in Austria and in Italy [22,27].
Seventh, the use of automatic patient data management 
systems can, by changing the sampling rate for the 
physiological variables, change the accuracy of the model. 
Bosman and colleagues [28] reported that predicted 
mortality was greater with data management charting 
than with manual charting for APACHE II, SAPS II, and 
MPM II.
Organ dysfunction scores
Organ failure scores are primarily designed to describe 
the degree of organ dysfunction rather than to predict 
survival. Th   e severity of organ dysfunction varies widely 
among individuals and within an individual over time 
and organ failure scores must be able to take both time 
and severity into account. Many organ dysfunction scores 
have been developed over the past few decades, but we 
will limit our discussion to three of the scores most 
commonly used in general ICU patients: the Logistic 
Organ Dysfunction System (LODS) [29], MODS [30], 
and SOFA [31] (Table 2).
Logistic Organ Dysfunction Score
Th  e LODS was developed using a database of 13,152 
admissions to 137 ICUs in 12 countries [29]. Using 
multiple logistic regression, 12 variables were selected to 
represent the function of six organ systems (neurologic, 
cardiovascular, renal, pulmonary, hematologic, hepatic). 
Th   e worst value for each variable in the ﬁ  rst 24 hours of 
admission is recorded, and for each system, a score of 0 
(no dysfunction) to 5 (maximum dysfunction) is awarded. 
Unlike the MODS and SOFA scores, LODS is a weighted 
system: for the respiratory and coagulation systems, the 
maximum score allowed is 3, and for the liver the 
maximum score is 1. LODS values, therefore, can range 
from 0 to 22.
Th   e LODS lies somewhere between a mortality predic-
tion score and an organ failure score as it combines a 
global score summarizing the total degree of organ 
dysfunction across the organ systems, and a logistic 
regression equation that can be used to convert the score 
into a probability of mortality. Within organ systems, 
greater severity of organ dysfunction was consistently 
associated with higher mortality [32], and a LODS of 22 
was associated with a mortality of 99.7% [29]. Th  e  LODS 
was not initially validated for repeated use during the ICU 
stay, but in a study of 1,685 patients in French ICUs, the 
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Table 2. Comparison of three organ dysfunction scores
Characteristics  LODS [29]  MODS [30]  SOFA [31]
Year of publication  1996  1995  1996
Selection of variables and their weights  Multiple logistic regression  Literature review and logistic  Panel of experts
     regression
Variables used to assess organ dysfunction
  Neurologic  Glasgow Coma Scale  Glasgow Coma Scale  Glasgow Coma Scale
  Cardiovascular  Heart rate, systolic blood  Pressure-adjusted heart rate  Mean arterial blood pressure, 
   pressure    vasopressor  use
  Renal  Serum urea or urea nitrogen,   Serum creatinine  Serum creatinine, urine output
    creatinine, urine output
 Respiratory  PaO2/FiO2 ratio, mechanical  PaO2/FiO2 ratio  PaO2/FiO2 ratio, mechanical
   ventilation    ventilation
  Hematologic  White blood cell count,   Platelet count  Platelet count
   platelet  count
  Hepatic  Serum bilirubin, prothrombin time  Serum bilirubin  Serum bilirubin
LODS, Logistic Organ Dysfunction Score; MODS, Multiple Organ Dysfunction Score; SOFA, Sequential Organ Dysfunction Score.
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organ dysfunction during the ﬁ  rst week of ICU stay [33].
Multiple Organ Dysfunction Score
Th   e development of the MODS was based on a literature 
review of 30 publications that had characterized organ 
dysfunction [30,34]. Seven organ systems were then 
selected for further consideration (respiratory, cardio-
vascular, renal, hepatic, hematological, central nervous 
system, gastrointestinal), and variables for each organ 
system were chosen according to a set of ‘ideal descriptor’ 
criteria (Table  3). No accurate descriptor of gastro-
intestinal function could be identiﬁ  ed, so this system was 
not included in the ﬁ  nal model. For the cardiovascular 
system, Marshall and colleagues [30] created a composite 
variable, the pressure-adjusted heart rate (heart rate × 
central venous pressure/mean arterial pressure); in 
patients without a central line, this variable is assumed to 
be normal. For each of the six organs, the ﬁ  rst parameters 
of the day are used to calculate the score and a score of 0 
(normal) to 4 (most dysfunction) is awarded, giving a 
total maximum score of 24. Th   e score was developed in 
336 patients admitted to one surgical ICU and validated 
in 356 patients admitted to the same ICU [30]. Although 
not designed to predict ICU mortality, increasing MODS 
values do correlate with ICU outcome [30]. ICU mortality 
also increases with increasing numbers of failing organ 
systems [30,35]. Th   e delta MODS, deﬁ   ned as the 
diﬀ   erence between the MODS at admission and the 
maximum score, may be more predictive of outcome 
than individual scores [30].
Sequential Organ Failure Assessment
Th  e SOFA was developed in 1994 during a consensus 
conference [31]. Six organ systems (respiratory, cardio-
vascular, renal, hepatic, central nervous, coagulation) 
were selected based on a review of the literature, and the 
function of each is scored from 0 (normal function) to 4 
(most abnormal), giving a possible score of 0 to 24. Unlike 
the MODS score in which the ﬁ  rst value of each day is 
used, for the SOFA score, the worst value on each day is 
recorded. Another key diﬀ  erence is in the cardiovascular 
component; instead of the composite variable, the SOFA 
score uses a treatment-related variable (dose of vaso-
pressor agents). Th   is is not ideal, as treatment protocols 
vary among institutions, among patients and over time, 
but it is diﬃ   cult to avoid, especially for the cardiovascular 
system.
Th   e SOFA was initially validated in a mixed, medical-
surgical ICU population [31,36] and has since been 
validated and applied in various patient groups [37-39]. 
In a prospective analysis of 1,449 patients, a maximum 
total SOFA score greater than 15 correlated with a 
mortality rate of 90% [40]. Changes in SOFA score over 
time are also useful in predicting outcome. In a 
prospective study of 352 ICU patients, an increase in 
SOFA score during the ﬁ   rst 48 hours in the ICU, 
independent of the initial score, predicted a mortality 
rate of at least 50%, while a decrease was associated with 
an ICU mortality rate of just 27% [41]. In a prospective 
observational study of 1,340 patients with multiple organ 
dysfunction syndrome, Cabrè and colleagues [42] 
reported 100% mortality for patients with age over 
60 years, a total maximum SOFA greater than 13 on any 
of the ﬁ  rst 5  days of ICU admission, minimum SOFA 
greater than 10 at all times, and a positive or unchanged 
SOFA trend over the ﬁ  rst 5 days of ICU admission.
Discussion
Several studies have directly compared the various organ 
dysfunction scoring systems. Pettilä and colleagues [43] 
reported comparable discriminative power of APACHE 
III, LODS, SOFA, and MODS to predict hospital 
mortality in a single center study. Peres Bota and 
colleagues [44] reported no signiﬁ  cant diﬀ  erences between 
MODS and SOFA for mortality prediction in 949 general 
ICU patients. However, when using the cardio  vascular 
component, outcome prediction was better for the SOFA 
score at all time intervals compared to the MODS, a 
ﬁ  nding conﬁ  rmed by other studies [45]. In a multicenter 
study, Timsit and colleagues [33] reported good accuracy 
and internal consistency for both the SOFA and LODS. 
However, in a Canadian study of 1,436 ICU patients [45], 
SOFA and MODS had only a modest ability to discri minate 
between survivors and non-survivors. More recently, SOFA 
was reported to have superior discrimi  native ability for 
Vincent and Moreno Critical Care 2010, 14:207 
http://ccforum.com/content/14/2/207
Table 3. ‘Ideal’ descriptors of organ dysfunction in ICU 
patients
Simple and inexpensive
Routinely available in all ICUs
Reliable (intra and inter-observer)
Objective (that is, observer independent)
Specifi  c to the function of the organ in question
Therapy independent
Sequential (available at ICU admission or shortly thereafter and then at fi  xed 
periods of time)
Not aff  ected by transient, reversible abnormalities associated with 
therapeutic or practical interventions 
Refl  ect acute dysfunction of the organ in question but not chronic 
dysfunction
Reproducible in large, heterogeneous groups of ICU patients
Reproducible in several types of ICUs from diff  erent regions of the globe
Abnormal in one direction only
Using continuous rather than dichotomous variables
Modifi  ed from [34].
Page 5 of 9hospital mortality and unfavorable neurologic outcome 
compared to MODS in patients with brain injury [46].
Severity assessment based on nursing workload use
The Therapeutic Intervention Scoring System (TISS)
TISS was originally developed in 1974 to assess severity 
of illness and compare patient care based on the 
measurement of nursing workload [47]. Th  e original 
score included 57 therapeutic activities with points 
assigned for each activity conducted during a 24-hour 
period; higher values were given for more specialized or 
time-consuming activities. In 1983, the score was 
updated and expanded to include 76 items [48]. However, 
TISS-76 was criticized for being too time-consuming and 
cumbersome, and in 1996, a simpliﬁ  ed  version  was 
devised using advanced statistical analysis [49]. TISS-28 
includes just 28 items, divided into 7 groups: basic 
activities, ventilatory support, cardiovascular support, 
renal support, neurological support, metabolic support, 
and speciﬁ   c interventions. Th  e scoring is weighted to 
give a total score of 78. TISS-28 was validated in 22 
Dutch ICUs [49] and in 19 ICUs in Portugal [50]. 
According to this system, each nurse can provide care for 
46.35 TISS-28 points per shift, with each TISS-28 point 
requiring 10.6 minutes of each nurse’s shift. Th  is 
information can be useful for planning the allocation of 
nursing manpower, to evaluate the eﬃ   cacy in the use of 
nursing workload use and to objectively classify ICUs 
based on the amount (and not the complexity) of care 
provided [51].
Nine Equivalents of Nursing Manpower Use Score
NEMS was derived from the TISS-28 with the aim of 
creating a simpler system that would be more widely 
used [52]. Nursing activities are separated into nine 
categories: basic monitoring, intravenous medication, 
mechanical ventilatory support, supplementary venti  la-
tory care, single vasoactive medication, multiple vaso-
active medication, dialysis techniques, speciﬁ  c  inter-
ventions in the ICU, speciﬁ  c interventions outside the 
ICU. Each of these is awarded weighted points, giving a 
maximum score of 56. NEMS has been validated in large 
cohorts of ICU patients and is easy to use with almost no 
interrater variability [53]. Again, this system can be used to 
evaluate the eﬃ   cacy of nursing workload use at the ICU 
level so as to objectively classify ICUs based on the amount 
(and not only on the complexity) of care provided [51].
Nursing Activities Score
Based on the TISS-28, the Nursing Activities Score 
(NAS) includes several additional nursing activities not 
necessarily related to the severity of illness of the patients 
[54]. Th   e list of items was developed by consensus. Th  e 
average time consumption of the activities was 
deter  mined from a 1-week observational cross-sectional 
study and the results compared with those of the TISS-28 
items in a cohort of 99 ICUs in 15 countries. At the end 
of this process, a total of ﬁ  ve new items and 14 sub-items 
describing nursing activities in the ICU (for example, 
monitoring, care of relatives, administrative tasks) were 
added to the TISS-28 list. Th  e new activities accounted 
for 60% of the average nursing time; and in the 
development study, NAS activities accounted for 81% of 
the nursing time (versus 43% in TISS-28) [54].
Discussion
Th  ese scores have been used mainly to assess nurse 
staﬃ   ng in the ICU, although higher scores are associated 
with worse outcomes [55,56]. All the scores are limited 
by the items included, and can be prone to subjective 
interpretation and inﬂ  uenced by patient case-mix, local 
admission and discharge policies, and local management 
protocols. Use of these scores to compare units may, 
therefore, be diﬃ   cult; however, within a unit they can 
provide a valuable indication of changing workload 
needs. Th   ese scores may also be used to estimate overall 
costs for groups of ICU patients, although they are less 
reliable on an individual patient basis [57]. Instruments, 
such as the Work Utilization Ratio, which evaluates the 
total number of points actually scored divided by the 
total possible points, have been proposed to evaluate the 
eﬀ  ectiveness of the use of nursing workload resources 
[51]. A recent position statement by the European 
Federa  tion of Critical Care Nursing Associations recom-
mends that all units use such a system on a regular basis 
to monitor the eﬃ   ciency of the use of nursing manpower 
[58].
Other uses of scoring systems
In addition to their use in outcome prediction, organ 
function assessment, and nursing workload evaluation 
discussed above, scoring systems have several other 
potential uses, including use in clinical trials for case-mix 
comparisons and use in the assessment and comparison 
of ICU quality and performance.
Clinical trials
Scoring systems are increasingly being incorporated into 
clinical trial design. Outcome prediction scores, such as 
APACHE and SAPS, have been used for some time to 
compare patient populations in clinical trials and even 
for the identiﬁ  cation of eligible patients for inclusion. Th  e 
analysis of results from one recent randomized controlled 
study [59], which showed improved outcomes in patients 
with higher APACHE II scores, led to the drug under 
investigation, drotrecogin alfa (activated), being licensed 
in the United States for use only in patients with severe 
sepsis who are at a high risk of death, that is, those with 
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controversial approach and these scores were not 
designed for this purpose [60].
Th   e realization that mortality alone is inadequate as an 
outcome measure for interventional studies in ICU 
patients has led many trials, especially in sepsis, to 
include an organ dysfunction score as part of ongoing 
patient assessment so that eﬀ  ects on morbidity can also 
be evaluated. Increased economic pressure has also led to 
greater concerns about cost-eﬀ   ectiveness of new and 
established interventions and nursing workload scores 
are also being incorporated into clinical trial design, 
particularly for interventions likely to impact on nursing 
workload.
Assessment of ICU performance
Costs of care for an ICU patient have been estimated as 
being three times the costs of care for a general ward 
patient [61]. Monitoring ICU performance is, therefore, 
increasingly important in the ﬁ   ght to control hospital 
expenses. While crude mortality data may oﬀ  er some 
global guidance as to ICU performance, adjusting 
mortality rates according to disease severity, by using 
outcome prediction scores to calculate the standardized 
mortality ratio, can help improve quality assessment. 
Such severity-adjusted indicators can be used to assess 
performance of a single ICU over time or to compare 
several or more units. However, this approach has several 
limitations, including potential eﬀ   ects of pre-ICU 
admission factors, implications of diﬀ  erent ICU discharge 
policies [62], and eﬀ  ects of diﬀ  erent patient case-mix and 
hence disease severity between units or in the same unit 
at diﬀ   erent times [63]. Nevertheless, there are large 
variations in risk-adjusted mortality rates among hospi-
tals [20] and repeated quality assessment may help 
determine the reasons underlying these diﬀ  erences and 
enable programs to be developed to improve 
perfor mance.
Conclusions
General illness severity scores are widely used in the ICU 
to assess resource use, predict outcome, and characterize 
disease severity and degree of organ dysfunction. All the 
scores were developed to be used in mixed groups of ICU 
patients and their accuracy in subgroups of patients can 
be questioned; disease-speciﬁ   c scoring systems are 
increasingly being developed. As ICU populations 
change and new diagnostic, therapeutic and prognostic 
techniques become available, all the scoring systems will 
need to be updated. Importantly, the diﬀ  erent scoring 
systems have diﬀ  erent purposes and measure diﬀ  erent 
parameters; we believe they should be seen as comple-
menting each other, rather than competing with one 
another. For example, outcome prediction models cannot 
be used to assess the severity of individual organ 
dysfunctions or to monitor patient progress over time. 
Although organ dysfunction scores correlate with 
outcomes, this is not what they were developed for and 
outcome prediction should be left to scores such as the 
APACHE and SAPS systems. Th  e workload scores 
complete the picture by oﬀ  ering information on how the 
patient’s disease will impact on staﬃ   ng requirement and 
resource use. We envisage that, increasingly, all patients 
will be initially evaluated using a general outcome predic-
tion model computed on admission or within the ﬁ  rst 24 
hours, then by repeated organ failure (for example, 
SOFA) and nursing workload (for example, TISS-28) 
scores during their ICU stay. When used together, these 
three approaches could provide a more accurate 
indication of disease severity and prognosis, which could 
be of help both to the clinician in charge of the patient 
and to the manager involved in resource allocation and 
performance assessment.
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